| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2004-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e40ff860c1fe3dcd156de121ca6d5964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3624135f6d7ee662e8178c8e7aaa598
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec4b7e8f6f5155ba635477541433b089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5827562ddb73c8b5c36a3814e11c6cd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d25bc3ab53591ab6bb737f9e605e425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc4c25a2049ef2f2e0d8e6b7003159a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e423915a6d97dbf0698842ef7c77fd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6b49868b6ef05aa060b00f0661c6a0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6fd341b3e8658699a8d079decaf80a6 |
| publicationDate |
2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005048543-A1 |
| titleOfInvention |
CHRNA2 genetic markers associated with galantamine response |
| abstract |
Haplotypes in the CHRNA2 gene associated with cognitive response to galantamine treatment are disclosed. Compositions and methods for detecting and using these CHRNA2 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising galantamine or derivatives thereof that are approved for treating patients having one of these CHRNA2 haplotypes, methods and kits for predicting the response of an individual to galantamine based upon his/her haplotype profile, and methods for treating Alzheimer's patients based upon their haplotype profile. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7250258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005255494-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008166723-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005250118-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005260613-A1 |
| priorityDate |
2003-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |